Haemolysis after Amplatzer device closure of ventricular septal defect

Area of Science:

• Cardiology
• Medical Devices
• Hematology

Background:

• Transcatheter device closure is a common method for treating septal defects.
• Hemolysis has been observed following Amplatzer device implantation for various septal defects.
• Perimembranous ventricular septal defects (VSDs) are a subset of these defects.

Purpose of the Study:

• To report a case of hemolysis following Amplatzer perimembranous VSD device implantation.
• To highlight the occurrence of self-limiting hemolysis in this context.
• To contribute to the understanding of potential complications associated with transcatheter VSD closure.

Main Methods:

• Case report of a single patient.
• Review of clinical presentation and laboratory findings.
• Implantation of an Amplatzer perimembranous VSD device.

Main Results:

• The patient experienced hemolysis post-device implantation.
• The hemolysis was self-limiting and resolved without specific intervention.
• No long-term adverse effects were noted.

Conclusions:

• Amplatzer perimembranous VSD device closure can be associated with hemolysis.
• Hemolysis in this context may be self-limiting.
• Further monitoring and research are warranted for transcatheter VSD device complications.